Despite the strong evidence showing the effect of serum FABP1 concentration on liver diseases, the biological mechanisms by which FABP1 is involved in the pathogenesis of NAFLD are not well understood. The gene discussed is FABP1; the disease is metabolic dysfunction-associated steatotic liver disease.